Comment on

• Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.

  Silvestry FE, Naseer N, Wiegers SE, Hirshfeld JW Jr, Herrmann HC. Silvestry FE, et al. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):383-7. doi: 10.1002/ccd.21364. Catheter Cardiovasc Interv. 2008. PMID: 18288733
• ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.

  Ewert P, Söderberg B, Dähnert I, Hess O, Schuler G, Bussmann C, Bernhard J, Sick P. Ewert P, et al. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):398-402. doi: 10.1002/ccd.21360. Catheter Cardiovasc Interv. 2008. PMID: 18288739
• Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.

  Spies C, Timmermanns I, Reissmann U, van Essen J, Schräder R. Spies C, et al. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):390-5. doi: 10.1002/ccd.21383. Catheter Cardiovasc Interv. 2008. PMID: 18288745
• Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: A case report.

  Motreff P, Dauphin C, Souteyrand G. Motreff P, et al. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):412-6. doi: 10.1002/ccd.21339. Catheter Cardiovasc Interv. 2008. PMID: 18288748